Wells Fargo & Company »

Qualigen Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Qualigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Qualigen Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qualigen Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $21 39 0.54
2023-09-30 $37 37 1.00
2023-06-30 $33 36 0.92
2022-12-31 $34 26 1.31